Some experts say we’re in “the golden age of biotechnology.” Scientific advances are opening up possibilities for the treatment and prevention of diseases that...
Action was muted this morning to start the second quarter earnings season. Major financial firms start to release data today, beginning with Goldman Sachs...
Many biotech companies are reasonably small startups. Which means if a successful product is developed (then revenues, then earnings), share prices can skyrocket.
However, many...